MedTrace Logo

P3: Pacemaker Patient Profiling Study

NCT00294060 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2013

Last updated 2011-05-06

Study results available
· View outcomes & findings →

Summary

The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.

Conditions

  • Bradycardia

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Ravi Kanagala, MD · Franciscan Skemp Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00294060 on ClinicalTrials.gov